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Introduction  and  Objectives:  Use  of  invasive  physiological  assessment  in  patients  with  coronary
artery disease  varies  widely  and  is  perceived  to  be  low.  We  aimed  to  examine  adoption  rates
as well  as  patterns  and  determinants  of  use  in  an  unselected  population  undergoing  invasive
coronary  angiography  over  a  long  time  frame.
Methods:  We  retrospectively  determined  the  per-procedure  prevalence  of  physiological  assess-
ment in  40  821  coronary  cases  performed  between  2007  and  2018  in  two  large-volume  centers.
Adoption  was  examined  according  to  procedure  type  and  patient-  and  operator-related  varia-
bles. Its  association  with  relevant  scientific  landmarks,  such  as  the  release  of  clinical  trial  results
and practice  guidelines,  was  also  assessed.
Results:  Overall  adoption  was  low,  ranging  from  0.6%  in  patients  undergoing  invasive  coronary
angiography  due  to  underlying  valve  disease,  to  6%  in  the  setting  of  stable  coronary  artery
disease (CAD);  it  was  3.1%  in  patients  sustaining  an  acute  coronary  syndrome.  Of  scientific
landmarks,  FAME  1,  the  long-term  results  of  FAME  2  and  the  2014  European  myocardial  revas-
e  associated  with  changes  in  practice.  Publication  of  instantaneous
had  no  influence  on  adoption  rates,  except  for  a  higher  proportion
ble  CAD  patients  undergoing  percutaneous  coronary  interventioncularization  guidelines  wer
wave-free  ratio  (iFR)  trials  
of iFR  use.  In  42.9%  of  sta∗ Corresponding author.
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there  was  no  objective  non-invasive  evidence  of  ischemia,  nor  was  physiological  assessment
performed.  Younger  operator  age  (4.5%  vs.  4.0%  vs.  0.9%  for  ages  <40,  40-55  and  >55  years,
respectively;  p<0.001)  and  later  time  of  procedure  during  the  day  (2.9%  between  6  and  8  p.m.
vs. 4.4%  at  other  times)  were  independent  correlates  of  use  of  invasive  physiology.
Conclusions:  Our  study  confirms  the  low  use  of  invasive  physiology  in  routine  practice.  The
availability of  resting  indices  did  not  increase  adoption.  Strategies  are  warranted  to  promote
guideline  implementation  and  to  improve  patient  care  and  clinical  outcomes.
© 2021  Sociedade  Portuguesa  de  Cardiologia.  Published  by  Elsevier  España,  S.L.U.  This  is  an








Prevalência  e  determinantes  da  utilização  da  avaliação  funcional  invasiva  da  doença
coronária  em  40  821  procedimentos  consecutivos  ao  longo  de  12  anos
Resumo
Introdução  e  objetivos: A  avaliação  funcional  invasiva  da  doença  coronária  varia  significati-
vamente na  prática  clínica  e  em  geral  parece  ser  subutilizada.  O  objetivo  deste  estudo  foi
determinar  a  sua  adoção  no  mundo  real,  assim  como  estudar  os  padrões  e  os  principais
determinantes  da  sua  utilização,  numa  população  não  selecionada  de  doentes  submetidos  a
coronariografia  invasiva,  ao  longo  de  um  período  alargado.
Métodos:  A  prevalência  da  avaliação  funcional  invasiva  foi  determinada  retrospetivamente,  por
procedimento,  em  40  821  casos  realizados  entre  2007  e  2018,  em  dois  centros  de  grande  volume.
As taxas  de  adoção  foram  avaliadas  de  acordo  com  variáveis  relacionadas  com  o  procedimento,
com o  doente  e  com  o  operador,  assim  como  em  relação  com  marcos  científicos  relevantes,
como a  publicação  de  resultados  de  ensaios  clínicos  e  de  recomendações  internacionais.
Resultados:  De  acordo  com  o  contexto  clinico,  a  utilização  variou  entre  0,6%  em  doentes  sub-
metidos a  coronariografia  no  contexto  de  patologia  valvular  e  6%  em  doentes  com  doença
coronária estável  (DAC)  e  foi  3,1%  em  doentes  com  síndroma  coronária  aguda.  Dos  marcos
científicos estudados,  a  publicação  dos  resultados  do  estudo  FAME  1,  dos  resultados  a  longo
prazo do  FAME  2  e  das  Recomendações  para  a  Revascularização  da  ESC  de  2014  associaram-se
às taxas  de  adoção.  Para  além  de  um  aumento  da  utilização  do  iFR,  a  publicação  dos  ensaios
clínicos consubstanciando  clinicamente  o  seu  uso  não  influenciou  a  utilização  global  de  fisi-
ologia invasiva.  Em  42,9%  dos  doentes  com  DAC  estável  submetidos  a  angioplastia,  não  havia
referência  a  isquémia  objetivável  nem  foi  utilizada  fisiologia  invasiva.  A  idade  dos  operadores
(4,5% versus  4,0%  versus  0,9%  para  idades  <  40,  40-55  e  >  55  anos,  respetivamente;  p  <  0,001)
e a  hora  de  realização  do  procedimento  (2,9%  entre  as  6-8PM  versus  4,4%  durante  o  restante
dia) relacionaram-se  inversamente  com  a  utilização  de  fisiologia  durante  os  procedimentos.
Conclusões:  Esta  análise  confirma  a  baixa  de  utilização  da  avaliação  funcional  invasiva  na
prática clínica.  A  disponibilidade  de  evidência  sobre  o  uso  de  índices  não  hiperémicos  não
aumentou  a  adoção.  São  necessárias  estratégias  dirigidas  que  potenciem  a  implantação  das
recomendações, de  forma  que  o  manejo  dos  doentes  com  doença  coronária  e  os  benefícios
clínicos da  estratificação  invasiva  possam  ser  aprimorados.
© 2021  Sociedade  Portuguesa  de  Cardiologia.  Publicado  por  Elsevier  España,  S.L.U.  Este é  um




















ractional  flow  reserve  (FFR)-guided  revascularization  has
een  widely  validated  and  is  associated  with  added  net
enefits  in  patient-oriented  health  outcomes,  as  com-
ared  to  angiography  alone.1,2 The  instantaneous  wave
ree  ratio  (iFR)  has  proved  to  be  similar  to  FFR  con-
3,4erning  clinical  outcomes, and  additional  evidence
uggests  that  other  diastolic  pressure  indices  are  numer-
cally  similar  to  iFR  and  may  be  used  interchangeably.5,6






uring  diagnostic  and  interventional  procedures  in  daily
ractice  are  not  fully  clear,  despite  extensive  validation7
nd  guideline  recommendations,8,9 and  may  also  be  sub-
ect  to  geographical  variations.  In  addition,  there  is  no
onsensus  on  how  actual  adoption  should  be  calculated.
n  most  reports,  the  number  of  percutaneous  coronary
nterventions  (PCI)  is  used  as  the  denominator,  which
ay  result  in  underestimation,  as  it  does  not  account
or  procedures  in  which  revascularization  may  not  have
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The  aim  of  the  present  study  was  to  describe  the  preva-
ence  of  physiological  assessment  in  a  large  unselected
opulation  undergoing  invasive  coronary  angiography  (ICA)
n  an  unbiased  setting  over  a  long  12-year  time  span,  and  to
lucidate  its  patterns  and  determinants  of  use.
ethods
tudy  definitions  and  design  and  data  collection
ata  on  all  ICA  exams  performed  for  any  clinical  indication
n  two  large-volume  centers  in  Portugal  between  January
007  and  December  2018  were  analyzed  retrospectively.
atient-,  angiographic-  and  procedure-related  data  were
ecorded  in  a  dedicated  electronic  database  (Cardiobase®,
nfortucanoTM)  at  the  time  of  the  index  procedure  by  the
ttending  team.  Information  was  extracted  separately  from
ach  center’s  database  and  then  merged  into  a  single
ataset.  To  ensure  consistency,  similar  queries  were  used  for
ata  retrieval.  All  patients  provided  written  informed  con-
ent  for  the  procedure  and  data  collection  in  accordance
ith  local  institutional  review  board  guidelines.
Use  of  invasive  functional  assessment  was  assessed  per
rocedure.  Diagnostic  procedures  in  which  PCI  was  deferred
ased  on  invasive  physiology  were  also  considered  when
etermining  adoption  rates.  Functional  studies  included
FR,  resting  full-cycle  distal-to-aortic  pressure  ratio  (Pd/Pa)
nd  iFR.  Attempted  percutaneous  coronary  intervention
ncluded  all  cases  in  which  PCI  was  decided  and  attempted,
egardless  of  procedural  success.
The  adoption  of  physiological  assessment  was  analyzed
ver  the  study  period  according  to  scientific  landmarks,
hich  included  the  publication  of  relevant  clinical  tri-
ls  and  the  European  guidelines  on  the  management
f  stable  coronary  artery  disease  (CAD)  and  myocardial
evascularization,9--11 and  also  according  to  operator  experi-
nce,  time  of  the  procedure  during  the  workday,  availability
nd  type  of  baseline  non-invasive  testing  prior  to  ICA,  CAD
xtent  and  whether  or  not  PCI  was  subsequently  performed.
tudy  population  and  definition  of  the  clinical
ndication for  coronary  angiography
ll  patients  undergoing  ICA  for  any  clinical  indication  were
ncluded.  Indications  were  classified  as  stable  CAD,  ongoing
cute  coronary  syndrome  (ACS),  recent  ACS,  valve  disease,
r  miscellaneous  indications.  Uniform  definitions  of  each
linical  indication  are  provided  in  the  online  Supplementary
aterial.
tatistical  analysis
ontinuous  variables  are  expressed  as  means  and  standard
eviations  and  were  compared  using  the  unpaired  t  test
r  the  Mann-Whitney  U  test,  as  appropriate.  Categorical
ariables  are  expressed  as  proportions  and  were  compared
sing  the  chi-square  test.  Normality  was  tested  with  the








ogia  xxx  (xxxx)  xxx--xxx
Independent  predictors  of  the  use  of  invasive  physiol-
gy  were  assessed  using  binary  logistic  regression  models.
o  examine  the  impact  of  time-varying  scientific  landmarks,
he  variable  was  entered  in  the  model  as  categorical.  Use
f  a  repeated  contrast  method  means  that  estimations  rep-
esent  the  odds  between  contiguous  categories,  rather  a
omparison  with  any  given  reference  category.  Model  cal-
bration  and  discriminative  power  were  assessed  with  the
osmer-Lemeshow  goodness-of-fit  test  and  the  area  under
he  receiver  operating  characteristic  curve,  respectively.
 two-sided  p-value  of  less  than  0.05  was  considered  to
ndicate  statistical  significance.  Statistical  analysis  was  per-
ormed  with  IBM® SPSS® Statistics  version  23.
esults
opulation  baseline  characteristics
etween  January  2007  and  December  2018,  40  821  proce-
ures  were  performed,  in  which  PCI  was  attempted  in  42.1%
f  cases  (n=17  183).  ACS  was  the  most  common  indication  for
CA  (35.5%  ongoing  ACS  and  8%  recent  ACS  cases).  Patients’
aseline  characteristics  and  clinical  indications  for  ICA  are
urther  detailed  in  Table  1.
verall  adoption  of  invasive  physiology  according
o indications  for  invasive  coronary  angiography
ver  the  study  period,  physiology  assessment  was  used
n  1631  procedures  (4%).  Regarding  the  main  clinical
ndications,  adoption  was  6.0%  in  stable  CAD,  2.7%  in
atients  suffering  ongoing  non-ST  elevation  ACS,  5.4%  in
atients  with  recent  ACS  (mostly  for  assessment  of  resid-
al  non-culprit  lesions  after  primary  PCI),  0.6%  in  patients
ndergoing  ICA  due  to  underlying  valve  disease,  and  2.0%  in
ther  miscellaneous  indications.  Adoption  was  4.1%  consid-
ring  all  attempted  PCI  procedures  as  the  denominator
n=17  183)  and  6.4%  in  stable  CAD  patients  undergoing  PCI
Supplementary  Figure  S10).
doption  of  invasive  physiology  according  to
cientific landmarks
ates  of  invasive  physiology  over  time,  as  well  as  their  rela-
ionship  with  relevant  landmarks,  both  overall  and  within
he  main  clinical  settings,  are  represented  in  Figure  1  and  in
upplementary  Figure  S1A.  Adoption  increased  significantly
rom  0.9%  to  4.0%  after  the  publication  of  FAME  11 in  2009
nd  remained  stable  thereafter,  as  no  major  changes  were
ssociated  with  the  release  of  early  results  from  FAME  2.12
lthough  the  absolute  annualized  adoption  rate  was  higher
fter  2015  (5%  vs.  4%  in  the  previous  period;  p=0.01),  closer
nalysis  demonstrates  that  it  actually  started  rising  in  late
014,  temporally  coinciding  with  the  publication  of  the  two-
ear  results  of  the  FAME  2  study  (Supplementary  Figure
1).13 Finally,  following  the  publication  of  the  two  iFR  out-
ome  trials3,4 in  early  2017,  no  increase  was  noted  in  the
se  of  invasive  physiology  (either  overall  or  in  stable  CAD),
lthough  the  proportion  of  cases  using  iFR  rather  than  FFR
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Table  1  Baseline  patient  and  procedural  characteristics  in  the  overall  cohort  and  according  to  use  of  invasive  physiology  in











Age,  years,  mean  ±  SD  66.2±12  66.2±12.1  65.1±10.9  <0.001
Male gender  27  239  (66.7%)  26  073  (66.5%)  1166  (71.5%)  <0.001
Previous clinical  history
Diabetes  12  686  (31.1%)  12  088  (30.8%)  598  (36.7%)  <0.001
Hypercholesterolemia  23  483  (57.5%)  22  417  (57.3%)  1066  (65.5%)  <0.001
Hypertension  30  108  (73.8%) 28  845  (73.7%) 1263  (77.5%) 0.001
Smoking history 15  671  (38.4%) 14  989  (38.3%) 682  (41.8%) 0.004
Family history  of  CVD  3477  (8.5%)  3308  (8.5%)  169  (10.4%)  0.006
Peripheral arterial  disease  2407  (5.9%)  2311  (5.9%)  96  (5.9%)  0.987
Stroke 3161  (7.7%)  3049  (7.8%)  112  (6.9%)  0.346
Previous myocardial  infarction 9251  (22.7%)  8430  (21.5%)  438  (26.9%)  <0.001
Previous PCI 9733  (23.8%)  9109  (23.2%)  558  (34.2%)  <0.001
Previous CABG 3053  (7.5%) 2973  (7.6%)  80  (4.9%)  <0.001
Cardiomyopathy  144  (0.36%) 134  (0.3%) 10  (0.6%)  0.082
Valve disease  (moderate  or  severe) 5896  (14%) 5824  (14.9%)  72  (4.4%)  <0.001
Heart transplantation 35  (0.1%) 35  (0.1%) 0  --
Clinical setting  <0.001
Stable disease  16  223  (39.7%)  15  251  (39.1%)  972  (59.6%)
Ongoing ACS  16  109  (39.5%)  15  676  (40.2%)  433  (26.5%)
Recent ACS  3234  (7.9%)  3060  (7.8%)  174  (10.7%)
Valvular heart  disease  4017  (9.8%)  3993  (10.2%)  24  (1.5%)
Miscellaneous  1075  (2.6%)  1054  (2.7%)  21  (1.3%)
Not reported  163  (0.4%)  156  (0.4%)  7  (0.4%)
Angiographic  findings  <0.001
All <50%  lesions  15  324  (37.5%)  14  978  (38.2%)  346  (21.2%)
1-vessel disease  9627  (23.6%)  9107  (23.2%)  520  (31.9%)
2-vessel disease  8315  (20.4%)  7862  (20.1%)  453  (27.8%)
3-vessel disease  7555  (18.5%)  7243  (18.5%)  312  (19.1%)
Coronary intervention
PCI  performed/attempted 17  183  (42.1%) 16  477  (42%) 706  (43.3%) 0.319
ACS: acute coronary syndrome; CABG: coronary artery bypass grafting; CVD: cardiovascular disease; PCI: percutaneous coronary inter-
vention; SD: standard deviation.
F  201








igure  1  Use  of  physiological  assessment  between  2007  and
opulation  and  in  the  main  clinical  settings.  ACS:  acute  coronar
ncreased  (Figure  2).  These  trends  were  consistent  across
he  stable  CAD  and  ACS  clinical  settings,  which  comprised
ore  than  80%  of  all  procedures.
European  guidelines  on  myocardial  revascularization
ere  issued  in  August  2013,11 September  201410 and  August






8  and  trends  according  to  scientific  landmarks  in  the  overall
drome;  CAD:  coronary  artery  disease.
CA  in  the  setting  of  stable  CAD,  a  significant  1.67-fold
ncrease  (95%  confidence  interval  [CI]  1.28-2.19;  p<0.001)
n  adoption  rates  (from  4.7%  to  8%)  was  seen  in  the  period
ollowing  the  release  of  the  2014  guidelines,  which  also
oincided  with  the  publication  of  the  long-term  (two-year)
esults  of  the  FAME  2  study  (Supplementary  Figure  S1B).
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Figure  2  Relative  use  of  fractional  flow  reserve  (F
elationship  between  physiological  assessment
nd operator  experience
here  was  a  statistically  significant  and  independent  asso-
iation  between  operator  experience  and  use  of  invasive
hysiology.  Procedures  performed  by  younger  physicians
ere  significantly  more  likely  to  include  physiological  assess-
ent,  both  overall  --  4.5%  vs.  4.0%  vs.  0.9%  (p<0.001)  --  and
n  stable  CAD  --  7.4%  vs.  5.1%  vs.  1.5%  (p<0.001)  --  for  ages
40,  40-55  and  >55  years,  respectively  (Figure  3  and  Table  2).
rends  in  the  use  of  physiological  assessment  in
igh- versus  low-adoption  operatorsor  the  purpose  of  this  analysis,  considering  the  average
verall  prevalence,  the  threshold  for  high  versus  low  adop-




igure  3  Adoption  of  physiological  assessment  according  to  operat
xis as  a  surrogate  of  operator  experience.  CAD:  coronary  artery  dis
5
and  instantaneous  wave-free  ratio  (iFR)  over  time.
ncluding  all  procedures.  All  operators  <40  years-old  were
lassified  as  high  adopters  (according  to  the  study  criteria),
ersus  none  in  the  age  group  >55  years.  Temporal  trends
iverged  in  high  versus  low  adopters.  While  in  the  former
doption  followed  the  previously  described  general  pattern,
n  the  latter  it  was  mostly  insensitive  to  scientific  landmarks
Supplementary  Figure  S2).  In  the  low-adopter  group,  only
he  FAME  1  landmark  was  associated  with  an  increase  in
doption  (adjusted  odds  ratio  [OR]  7.0,  relative  to  the  prior
ime  period;  95%  CI  2.4-19.9;  p<0.001),  but  still,  overall
enetration  remained  less  than  3%.
doption  of  physiological  assessment  according  to
ime of  the  procedure  during  the  workday
he  proportion  of  procedures  in  which  physiological  assess-
ent  was  used  decreased  progressively  during  the  day,  from
or  experience.  Operator  age  groups  are  shown  on  the  horizontal
ease.
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Table  2  Multivariate  predictors  of  physiological  assessment  during  invasive  coronary  angiography  (n=1631).
Variable  OR  95%  CI  p
Clinical  setting  (stable  CAD  vs.  other  settings)  2.09  1.84-2.37  <0.001
Patient age  (per  1-year  increase)  0.98  0.98-0.99  <0.001
Previous PCI  1.51  1.36-1.69  0.03
Previous CABG  0.39  0.30-0.49  0.034
Diabetes 1.12  1.01-1.25  0.03
Baseline stress  test  performed 1.15  1.01-1.30  0.025
Operator experience  (reference  category  >55  years  old)
Fellow  or  <40  years  old 5.1 3.69-7.24  <0.001
40-55 years  old 4.45 3.16-3.27  <0.001
CAD extent
Overall  1.27  1.21-1-33  <0.001
3-vessel disease  0.82  0.70-0.95  0.012
2-vessel disease 1.03  0.90-1.18  0.582
1-vessel disease 2.5 2.2-2.9  <0.001
All <50%  lesions -- --  --
Time of  procedure  during  the  daya 0.93 0.90-0.96  <0.001
Relevant scientific  landmarksb
DEFINE-FLAIR  and  iFR-SwedeHEART  1.01  0.87-1.18  0.813
FAME 2  (long-term  results)  1.29  1.11-1.49  0.001
FAME 2  (initial  results)  0.91  0.79-1.05  0.217
FAME 1  4.16  3.08-5.6  <0.001
CABG: coronary artery bypass grafting; CAD: coronary artery disease; CI: confidence interval; OR: odds ratio; PCI: percutaneous coronary
intervention.
Hosmer-Lemeshow goodness-of-fit test: chi-square=13.2; p=0.13. Area under the curve=0.72 (95% CI 0.71-0.74).
a Per each two-hour increase during the regular workday (from 8 a.m. to 8 p.m.).
b ORs are for comparisons between contiguous categories. There is no statistic for ‘All lesions <50%’ as it is the last category.























igure  4  Proportion  (A)  and  distribution  (B)  of  invasive  coron
o time  of  the  procedure  during  the  regular  workday.
.1%  during  the  first  two  hours  (8-10  a.m.)  to  3.1%  between
 and  8  p.m.  (Figure  4).  The  majority  of  cases  with  invasive
easurements  (61%)  were  performed  between  10  a.m.  and
 p.m.  (Figure  4B).
ssociation  between  physiological  assessment  and
aseline  non-invasive  testing,  coronary  disease
urden and  percutaneous  coronary  interventionhe  overall  prevalence  of  non-invasive  stress  tests  was
5.7%,  varying  widely  between  clinical  settings  (from  2%  to
3.9%;  Supplementary  Figure  S3).  The  association  between






ngiography  cases  including  physiological  assessment  according
as  highly  inconsistent.  In  stable  CAD  and  recent  ACS
atients,  the  availability  of  functional  information  prior
o  ICA  was  not  associated  with  the  use  of  invasive  phys-
ology  (5.9%  vs.  6.1%  for  stable  CAD  and  3.6%  vs.  5.6%
or  recent  ACS,  in  procedures  with  and  without  base-
ine  testing,  respectively  (p=NS;  Supplementary  Figure  S4).
owever,  in  ongoing  ACS  adoption  was  higher  in  cases  in
hich  a  baseline  stress  test  was  available  (6.7%  vs.  2.4%;
<0.001).  Among  stable  CAD  cases  (n=16  223),  the  preva-
ence  of  physiological  assessment  was  highest  in  multislice
omputed  tomography  (MSCT)-based  referrals  and  in  those
ith  a  negative  non-invasive  test  at  baseline  (11%  and  9.6%
espectively;  Supplementary  Figure  S5).  In  patients  under-
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either  anatomical  or  functional),  physiological  assessment
as  used  in  only  6%  of  cases.  Adoption  was  similar  in
rocedures  with  non-specific  positive  ECG  stress  tests  and
maging  tests  (6.8%  and  6.3%,  respectively),  but  was  almost
wice  as  high  (11.9%)  in  patients  in  whom  a  baseline  stress
est  had  been  performed  but  without  evidence  of  ischemia
Supplementary  Figures  S6  and  S7).  Moreover,  in  42.9%  of
table  CAD  patients  undergoing  PCI,  there  was  no  record  of
nducible  ischemia  on  non-invasive  testing  (including  stress
CG),  nor  was  physiological  assessment  performed.
On  univariate  analysis,  there  was  no  consistent  asso-
iation  between  CAD  extent  and  the  pattern  of  invasive
hysiology  (Figure  5).  When  all  cases  are  taken  together,
hysiological  assessment  was  more  frequently  performed
n  patients  with  one-  or  two-vessel  disease  (5.4%  in  both)
han  in  three-vessel  disease  (4.1%)  or  in  cases  with  less
evere  disease  (2.3%).  In  stable  CAD,  adoption  actually
ecreased  through  the  spectrum  of  increasing  CAD  sever-
ty  (9.1%  vs.  8.3%  vs.  5.8%  for  one-,  two-  and  three-vessel
isease,  respectively)  and  in  ongoing  ACS  it  was  numerically
imilar  from  mild  to  three-vessel  disease  (2.3%  vs.  2.9%  vs.
.3%  vs.  2.5%).
Considering  only  interventional  procedures,  cases  in
hich  physiological  assessment  was  used  had  a  higher  dis-
ase  burden  (1.8±0.9  vs.  1.6±0.9  vessels  with  >50%  stenosis;
<0.001).  Overall  prevalence  of  PCI  was  similar  in  cases
ith  and  without  physiological  assessment  (42%  vs.  43.3%;
=0.30;  Supplementary  Figure  S8);  however,  the  ratio  of  ves-
els  treated  by  PCI  to  the  number  of  diseased  vessels  was
arginally  lower  in  invasive  physiology-guided  cases,  sug-
esting  less  extensive  intervention  (Supplementary  Figure
9).
ndependent  predictors  of  use  of  coronary
hysiological  assessment
n  a  multivariate  binary  regression  model,  the  stable  CAD
linical  setting  (versus  other  indications),  diabetes,  prior  PCI
nd  the  availability  of  baseline  stress  tests  were  positive
ndependent  predictors  of  the  use  of  invasive  physiology.
rior  CABG,  time  of  the  procedure  during  the  workday  and
ncreasing  patient  age  were  inversely  associated  with  the
ikelihood  of  use  of  invasive  physiology  in  the  index  pro-





igure  5  Use  of  physiological  assessment  according  to  coronary  a
oronary syndrome;  CAD:  coronary  artery  disease.  *p<0.001;  §  p=0.0
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ears  old  --  were  four  to  five  times  more  likely  to  use  inva-
ive  physiology  than  older  interventionists  (>55  years  old).
s  pointed  out  above,  the  overall  association  between  CAD
xtent  and  use  of  physiology  was  inconsistent.  In  the  multi-
ariate  model,  increasing  CAD  extent  (per  diseased  vessel)
as  associated  with  a  significant  1.2-fold  average  greater
ikelihood  of  operators  performing  physiological  assessment.
owever,  this  was  driven  by  a  higher  OR  in  patients  with  one-
nd  two-vessel  disease  compared  both  to  milder  cases  and
o  three-vessel  disease.  Adjusted  ORs  of  the  independent
redictors  as  well  as  model  characteristics  are  summarized
n  Table  2.
iscussion
ur  findings,  which  refer  to  a  large  cohort  of  patients  under-
oing  ICA  over  a long  time  frame  and  encompassing  a  wide
ange  of  clinical  scenarios,  underscore  (1)  the  low  use  of
nvasive  physiological  assessment  of  CAD  in  daily  practice,
egardless  of  the  clinical  setting;  (2)  that  factors  unre-
ated  to  procedural  and  patient  characteristics  significantly
nfluenced  penetration;  and  (3)  that  the  clinical  evidence
ustaining  the  use  of  adenosine-free  indices  (mainly  iFR)  did
ot  result  in  a  significant  increase  in  adoption.
ow  adoption  rates
espite  mounting  evidence  from  randomized  tri-
ls  and  large  registries14,15 and  also  strong  guideline
ecommendations,8,9,16 it  is  known  that  the  use  of  invasive
hysiology  varies  widely  and  is  generally  perceived  to  be
ower  than  expected.17--20 Our  results  are  in  line  with  these
bservations.
Although  trends  may  be  changing  worldwide,21 partly  due
o  more  effective  reimbursement  policies,  the  underuse  of
nvasive  physiology-guided  management  is  due  to  different
easons,  ranging  from  technical  and  operator-related  issues
o  site-specific  and  regional  determinants.  In  some  settings,
actors  such  as  unavailability  or  lack  of  funding  have  been
inpointed  as  the  main  reasons  for  the  low  uptake.18 Nev-
rtheless,  there  is  evidence  that  even  when  all  potential
xternal  constraints  are  overcome,  visual  estimation  con-
inues  to  dominate  treatment  decisions  for  intermediate
rtery  disease  extent  in  the  main  clinical  settings.  ACS:  acute

















































































































ARTICLEEPC-1786; No. of Pages 11
L.  Raposo,  M.  Gonç
tenoses.22 The  extent  to  which  similar  factors  apply  to  our
ample  cannot  be  accurately  quantified.  However,  consid-
ring  the  wide  availability  of  the  technology  in  Portugal
nd  the  virtually  unrestricted  reimbursement  policies,  it  is
nlikely  that  financial  issues  have  played  a  significant  role.
linical  correlates  of  use  of  invasive  physiology
espite  overall  low  adoption  rates,  the  stable  CAD  clinical
etting  was  an  independent  predictor  of  use  of  physiological
ssessment.  This  may  be  influenced  by  current  recommen-
ations,  which  are  mostly  applicable  to  stable  CAD.  Diabetes
nd  previous  PCI  were  also  associated  with  higher  adop-
ion.  Both  subgroups  had  more  extensive  CAD,  which  was
tself  an  independent  predictor.  The  use  of  FFR  and  iFR  in
atients  with  diabetes  has  recently  been  analyzed  in  large
ohorts  and  both  indices  have  been  shown  to  retain  diagnos-
ic  and  prognostic  reliability.23,24 Conversely,  prior  CABG  and
ncreasing  patient  age  were  both  inversely  associated  with
he  use  of  invasive  physiology.  It  is  conceivable  that  factors
uch  as  CAD  complexity  and  comorbidity  may  have  rendered
perators  less  likely  to  consider  additional  diagnostic  tech-
iques.  Also,  concerns  about  microvascular  dysfunction  and
denosine  hyporesponsiveness  in  elderly  patients  have  been
oted,  compared  to  younger  patients.13,25
elationship  with  non-invasive  functional  tests,
oronary artery  disease  extent  and  use  of
ercutaneous  coronary  intervention
ur  findings  underscore  important  complexities  of  patient
orkup,  for  which  straightforward  explanations  may  not
e  attainable  based  on  available  data  alone.  Consider-
ng  the  main  clinical  settings  (stable  CAD  and  ACS),  no
onsistent  pattern  could  be  detected  regarding  the  asso-
iation  between  the  availability  of  stress  tests  at  baseline
including  stress  ECG)  and  the  use  of  invasive  physiology.
perators  could  have  been  expected  to  perform  invasive
hysiology  mostly  in  the  absence  of  prior  non-invasive  tests
or  the  detection  and/or  localization  of  ischemia.  How-
ver,  this  was  not  the  case,  except  in  the  subgroup  with
ecent  ACS,  at  least  in  part  because  many  of  these  cases
ere  patients  with  ST-elevation  myocardial  infarction  and
ystander  disease,  in  whom  the  prevalence  of  stress  tests
as  low  (Supplementary  Figure  S4).  Another  possible  expla-
ation  relies  on  the  observation  that  most  functional  tests
ere  treadmill  ECG  stress  tests  and  single-photon  emission
omputed  tomography  myocardial  perfusion  imaging,  which
ay  lack  accuracy  in  a  real-world  environment,26,27 leading
perators  to  use  invasive  physiology  to  clarify  non-invasive
ndings,  as  in  MSCT,  in  which  no  functional  information  is
vailable  at  all.  Nevertheless,  the  overall  low  penetration
f  physiological  assessment  renders  further  conclusions  elu-
ive.
The  benefits  of  PCI  in  stable  patients  are  thought  to  be
inked  to  the  severity  of  inducible  ischemia,28,29 although
ecent  evidence  from  randomized  trials  has  questioned  this
pproach.30,31 Even  if  this  cannot  be  extended  to  other  clin-
cal  settings,  particularly  ongoing  ACS  and  valve  disease,
t  is  noteworthy  that  in  our  large  cohort  a  high  propor-
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f  inducible  ischemia,  nor  were  invasive  measurements
erformed.  Although  the  ultimate  reasons  driving  PCI  in
hese  cases  --  such  as  symptom  severity,  specific  angiogra-
hic  findings  or  information  from  intravascular  imaging  --
annot  be  definitively  ascertained,  this  suggests  that  inap-
ropriate  revascularization  potentially  remains  a  significant
roblem.21 The  perceived  safety  of  current  revascularization
echniques  (notably  PCI)  may  be  driving  a  persistent  unwill-
ngness  to  adopt  coadjuvant  technologies  such  as  invasive
hysiological  assessment.  However,  our  findings  reinforce
he  need  for  the  implementation  of  strategies  aiming  at  a
ider  adoption  of  physiological  assessment,  if  clinical  ben-
fits  are  to  be  optimized.32,33
The  routine  integration  of  physiological  measurements
n  the  management  of  patients  with  CAD  has  moved  pres-
ure  indices  to  the  center  of  the  diagnostic  workflow  and
isk  stratification  of  patients  undergoing  ICA.24 The  more
xtensive  the  assessment  and  the  greater  the  extent  of  CAD,
he  more  likely  are  changes  in  the  patient’s  management  to
ccur,  particularly  when  lesions  are  in  fact  intermediate.14,15
ignificant  heterogeneity  was  found  in  our  study  concern-
ng  the  use  of  invasive  physiology  according  to  the  extent
f  CAD  (as  measured  by  the  number  of  diseased  vessels).
lthough  CAD  extent  was  an  overall  predictor  of  adop-
ion  across  all  main  clinical  settings,  lesion  assessment  was
lways  lower  in  three-vessel  CAD.  A  higher  prevalence  of
hronic  total  occlusions  and  other  features  of  anatomical
nd  clinical  complexity  may  have  rendered  these  patients
orse  candidates  for  assessment  with  pressure  wires,  which
n  their  own  may  lack  important  mechanical  character-
stics  as  compared  to  regular  workhorse  guidewires.  Our
ata  support  this  observation,  as  three-vessel  CAD  patients
ere  older,  had  lower  creatinine  clearance,  and  were  more
ikely  to  have  multiple  risk  factors,  previous  CABG  and  clini-
ally  overt  vascular  disease  elsewhere  (analysis  not  shown).
inally,  it  should  be  noted  that  the  proportion  of  patients
ndergoing  PCI  was  no  lower  in  cases  that  included  physio-
ogical  assessment  than  in  those  that  did  not.  This  is  in  line
ith  prior  observations  from  the  POST-IT  registry  and  goes
gainst  the  common  belief  that  the  routine  use  of  physio-
ogical  assessment  will  reduce  PCI  rates,  as  reclassification
etween  management  strategies  ultimately  allows  patients
ho  would  not  otherwise  have  been  treated  to  undergo
CI.14
atient-independent  determinants  of  adoption:
mpact of  operator  experience  and  scientific
vidence
or  decades  angiography  has  been  the  gold  standard  for
uiding  revascularization,  and  studies  providing  evidence
or  myocardial  revascularization  have  been  mostly  based  on
ngiography  alone.  It  may  thus  not  be  surprising  that  older
perators,  who  have  been  trained  for  many  years  in  this
echnique,  are  less  likely  to  use  and  rely  on  pressure  gradi-
nts  to  decide  on  management  of  obstructive  CAD.  Unlike  in
revious  reports,  in  which  no  difference  in  FFR  use  by  oper-
tor  age,  practice  setting,  or  case  volume  was  observed,18
n  our  large  dataset  we  demonstrate  that  younger  interven-
ionists  were  significantly  more  likely  to  use  physiological
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ignificant  determinants.  This  may  be  due  to  a  variety  of
easons,  such  as  increased  awareness  of  the  limitations  of
ngiography  as  a  surrogate  of  lesion  severity,34 changes  in
raining  patterns,  and  easier  adoption  of  new  technolo-
ies.  For  similar  reasons,  the  penetration  of  physiological
ssessment  could  be  expected  to  be  related  to  the  available
linical  evidence.  To  assess  this,  we  assessed  its  temporal
elationship  with  scientific  landmarks.  All  cases  considered,
here  was  a  significant  association  with  the  publication  of
AME  11 and  the  near-simultaneous  release  of  the  two-
ear  results  of  FAME  213 and  the  2014  European  myocardial
evascularization  guidelines10 (Supplementary  Figure  S1B).
verall  adoption  appears  to  have  been  insensitive  to  the
nitial  results  of  the  FAME  2  study1 as  well  as  to  the  pub-
ication  of  the  two  main  randomized  trials  comparing  iFR
nd  FFR  in  clinical  outcomes.3,4 Importantly,  trends  were
imilar  across  the  main  clinical  settings,  despite  higher  abso-
ute  penetration  in  stable  CAD.  Also,  high  adopters  (all  of
hom  belonged  to  younger  age  groups)  followed  (and  pos-
ibly  were  the  drivers  of)  the  general  trend  (Figure  1  and
upplementary  Figure  S2).
The  fact  that  adoption  did  not  increase  with  the  advent  of
denosine-free  and  non-hyperemic  indices  (such  as  contrast
FR  and  iFR)  deserves  consideration.  Additional  reasons
hat  have  been  implicated  in  the  low  use  of  FFR  are
dverse  effects  of  hyperemic  agents,  the  costs  associ-
ted  with  adenosine,  contraindications  and  patient-related
iscomfort,20 all  of  which  have  contributed  to  the  pursuit
f  more  patient-friendly  techniques.  In  both  DEFINE-FLAIR3
nd  iFR-SWEDEHEART4 the  duration  of  the  procedure  was
horter  and  the  percentage  of  patients  who  developed
dverse  procedure-related  symptoms  was  lower  than  with
FR,  potentially  providing  a  solution  for  some  of  the  pre-
iously  reported  barriers.  Also,  contrast-induced  hyperemia
as  been  shown  to  be  an  adequate  surrogate  of  standard
denosine  for  FFR  determination.35,36 Still,  we  provide  clear
vidence  that  these  well-publicized  improvements  appeared
o  have  had  little,  if  any,  impact  on  the  adoption  of  inva-
ive  physiology.  As  overall  rates  remained  stable,  there  was
imply  a  larger  proportion  of  cases  using  iFR,  progressively
riving  FFR  use  down  to  less  than  30%  of  invasive  physiol-
gy  cases  toward  the  end  of  the  study  period  (Figure  2).
hether  or  not  this  observation  extends  to  other  countries
nd  practice  environments,  particularly  in  Europe,  remains
o  be  determined.
Finally,  it  is  noteworthy  that  the  time  of  day  the
rocedure  was  performed  during  the  regular  workday  inde-
endently  affected  the  likelihood  of  pressure  indices  being
ncorporated  in  patient  assessment,  as  it  decreased  by
 significant  7%  for  every  two  hours  throughout  the  day
Figure  4).  This  can  be  explained  mainly  by  logistical  factors,
ostly  in  the  cath  lab  setup  and  workflow,  as  well  as  by  the
eam’s  own  perceptions  of  potential  unwarranted  delays  and
dded  complexity  to  the  procedures,  despite  improvements
n  the  technique.  Inherent  limitations  can  and  should  be  pro-
ressively  overcome  by  increasing  operator  experience  and
mproving  cath  labs’  routines  and  logistics,  given  that  such
easures  are  justified  by  important  factors  such  as  reducedeed  for  further  testing14 and  possibly  unnecessary  coronary
nterventions.  Also,  it  is  reasonable  to  expect  that  tech-
ical  improvements  in  pressure  sensor-tipped  guidewires,
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mplementation  of  emerging  technologies,  such  as  real-time
ngiography  and  non-invasive  CCTA-derived  FFR  and  virtual
CI  planning,  may  overcome  some  of  these  hurdles  and  help
o  change  the  scenario  in  the  near  future.
trengths  and  limitations
espite  the  high  number  of  procedures,  encompassing  a
ide  range  of  clinical  indications,  our  data  were  obtained
rom  only  two  large-volume  centers,  and  it  could  be  argued
hat  these  may  not  be  representative  of  the  situation  in  the
ntire  country.  However,  based  on  the  Portuguese  Registry
n  Interventional  Cardiology,  the  rate  of  FFR-guided  PCI  was
n  the  range  of  0.2-0.8%  before  2009,  rising  to  2.6-3.1%  in
010-2012.37 These  estimates  mirror  our  results  in  that  same
eriod,  which  is  a  reassuring  confirmation  of  the  external
alidity  of  our  data.
The  full  spectrum  of  reasons  underlying  the  low  adoption
f  invasive  physiology  is  difficult  to  ascertain  and  there  is
o  bullet-proof  methodology  that  could  provide  unequivocal
nswers.  A  prospective  inquiry  on  why  invasive  physiology
ay  or  may  not  have  been  used  in  any  given  case  could
nduce  observation  bias  and  unwarranted  changes  in  usual
ractice.  On  the  other  hand,  a  retrospective  approach,  such
s  the  one  used  in  our  study,  necessarily  relies  on  the  quality
f  registry  data,  a  limitation  that  is  inherent  to  all  obser-
ational  studies.  However,  we  provide  an  unbiased  analysis
ased  on  variables  that  are  easy  to  collect  and  report  and
hus  potentially  less  prone  to  uncertainty.  Accurate  identifi-
ation  of  the  original  reasons  underlying  low  adoption  rates
hould  prompt  the  implementation  of  dedicated  strategies,
n  each  specific  setting.
onclusion
his  study  builds  on  the  evidence  concerning  the  suboptimal
se  of  invasive  physiological  assessment  in  routine  practice,
hich  is  due  in  part  to  issues  unrelated  to  patient  and  pro-
edural  characteristics.  The  availability  of  adenosine-free
ressure  indices  has  not  increased  adoption.  In  order  to
mprove  patient  outcomes,  dedicated  strategies  are  needed
oth  to  motivate  adherence  to  current  guidelines  and  to
ncrease  awareness  of  the  advantages  of  integrating  invasive
unctional  information  into  management  algorithms.
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